Alternatives to Xaira Therapeutics

AI foundation models predicting patient drug response to de-risk clinical trials

Generative AI drug discovery platform spanning target ID to clinical trials, with its own Phase III pipeline as proof.

All-in-human AI foundation models for precision neurology and CNS drug discovery

BenevolentAI: AI drug discovery knowledge graph for target discovery and repurposing

AI-driven CRISPR platform revealing causal disease-driving RNA pathways for immunology and oncology drug discovery

AI-native drug discovery partner building on and beyond AlphaFold for pharma R&D.

AI drug discovery engine pairing 2M weekly wet-lab experiments with a 50+ petabyte phenomics dataset

Tech-driven drug discovery and biologics manufacturing platform

Atomwise's APEX Protocol ML platform screens 10 billion compounds in under 30 seconds for small-molecule drug discovery

Generative biology platform for AI-designed protein therapeutics and de novo antibody discovery

Generative AI and robotics platform compressing drug discovery to under two years.

Physics-based molecular discovery platform for drug and materials design

AI-native biotech accelerating small-molecule drug discovery from design to clinic

Causal AI for human health, turning 20+ petabytes of cellular data into targeted therapeutics.

AI-native drug discovery platform turning 50PB+ cellular imaging into clinical-stage therapies

AI-driven drug discovery platform with 50+PB proprietary data and automated wet labs

AI-first medicinal chemistry platform for synthesis-aware drug discovery

AI co-scientist for biomedical research: multi-omics, drug discovery, and lab protocol reasoning

AI target discovery for neurotherapeutics targeting neural circuits across disorders

Open-source AI research assistant for accelerated drug discovery, self-hosted with full data control

Silico: mechanistic interpretability platform to understand, debug, and design AI models

Nimbus Therapeutics designs highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Oncology real-world evidence platform that turns patient data into AI-powered cancer research insights.

AI-driven clinical trial patient matching and recruitment from EMR data.

Cloud ELN, LIMS, and AI platform that unifies biotech R&D data for discovery teams.

FDA-cleared AI for cancer pathology diagnostics and biomarker discovery.

PathAI is an enterprise AI pathology platform for diagnostic accuracy and biopharma drug development.

AI-powered patient prescreening for clinical trials that scans EHRs daily and emails eligible candidates.

Open-source pre-trained transformer for DNA sequence analysis and genomic prediction.

AI-driven health data platform uniting patient care and clinical research